Ex Vivo Generation of Regulatory T Cells: Characterization and Therapeutic Evaluation in a Model of Chronic Colitis

Methods in Molecular Biology

Volumn 677, Issue , 2011, Pages 47-61

  Karlsson, Fridrik ^a   Robinson Jackson, Sherry A ^a   Gray, Laura ^a   Zhang, Songlin ^a   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Colitis; Inflammatory bowel disease; iTregs; Retinoic acid; TGF

Indexed keywords

BETA INTEGRIN; BETA7 INTEGRIN; FORKHEAD TRANSCRIPTION FACTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL; ARTICLE; CD4 LYMPHOCYTE COUNT; COLITIS; CULTURE TECHNIQUE; DISEASE MODEL; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PATHOLOGY; REGULATORY T LYMPHOCYTE; SPLEEN;

ANIMALS; CD4 LYMPHOCYTE COUNT; CELL CULTURE TECHNIQUES; COLITIS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; IMMUNOTHERAPY; INTEGRIN BETA CHAINS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 79952201845     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-869-0_4     Document Type: Chapter

References (20)

1. Sakaguchi, S. et al. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8–27.
2. Scheffold, A., Murphy, K.M. & Hofer, T. (2007) Competition for cytokines: T(reg) cells take all. Nat. Immunol. 8, 1285–1287.
3. Uhlig, H.H. et al. (2006) Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol. 177, 5852–5860.
4. Vignali, D.A., Collison, L.W. & Workman, C.J. (2008) How regulatory T cells work. Nat. Rev. Immunol. 8, 523–532.
5. Earle, K.E. et al. (2005) In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin. Immunol. 115, 3–9.
6. Tang, Q. et al. (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455–1465.
7. Battaglia, M., Stabilini, A. & Roncarolo, M.G. (2005) Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105, 4743–4748.
8. Taylor, P.A., Lees, C.J. & Blazar, B.R. (2002) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493–3499.
9. Chen, W. et al. (2003) Conversion of peripheral CD4+. J. Exp. Med. 198, 1875–1886.
10. Benson, M.J., Pino-Lagos, K., Rosemblatt, M. & Noelle, R.J. (2007) All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204, 1765–1774.
11. Fantini, M.C., Dominitzki, S., Rizzo, A., Neurath, M.F. & Becker, C. (2007) In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells. Nat. Protoc. 2, 1789–1794.
12. Kang, S.G., Lim, H.W., Andrisani, O.M., Broxmeyer, H.E. & Kim, C.H. (2007) Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol. 179, 3724–3733.
13. Mucida, D. et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256–260.
14. Fontenot, J.D. et al. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329–341.
15. Zheng, S.G., Wang, J.H., Wang, P., Gray, J.D. & Horwitz, D.A. (2007) IL-2 is essential for TGF-beta to convert naive CD4(+)CD25(−) cells to CD25(+)Foxp3(+) regulatory T cells and for expansion of these cells. J. Immunol. 178, 2018–2027.
16. Sun, C.M. et al. (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775–1785.
17. Hill, J.A. et al. (2008) Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 29, 758–770.
18. Mucida, D. et al. (2009) Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. Immunity 30, 471–472.
19. Thornton, A.M. & Shevach, E.M. (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287–296.
20. Ostanin, D.V. et al. (2009) T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G135–G146.